Author: Maggi, Fabrizio; Rosellini, Alfredo; Spezia, Pietro Giorgio; Focosi, Daniele; Macera, Lisa; Lai, Michele; Pistello, Mauro; de Iure, Antonio; Tomino, Carlo; Bonassi, Stefano; Russo, Patrizia
Title: Nicotine Upregulates ACE2 Expression and Increases Competence for SARS-CoV-2 in human pneumocytes Cord-id: s1jiuige Document date: 2021_3_5
ID: s1jiuige
Snippet: The COVID-19 pandemic has a variable degree of severity according to underlying comorbidities and life-style. Several research groups have reported an association between cigarette smoking and increased severity of COVID-19. The exact mechanism of action is largely unclear. We exposed low ACE2-expressing human pulmonary adenocarcinoma A549 epithelial cells to nicotine and assessed ACE2 expression at different times. We further used the nicotine-exposed cells in a virus neutralisation assay. Nico
Document: The COVID-19 pandemic has a variable degree of severity according to underlying comorbidities and life-style. Several research groups have reported an association between cigarette smoking and increased severity of COVID-19. The exact mechanism of action is largely unclear. We exposed low ACE2-expressing human pulmonary adenocarcinoma A549 epithelial cells to nicotine and assessed ACE2 expression at different times. We further used the nicotine-exposed cells in a virus neutralisation assay. Nicotine exposure induces rapid and long-lasting increases in gene and protein expression of the SARS-CoV-2 receptor ACE2, which in turn translates into increased competence for SARS-CoV-2 replication and cytopathic effect. These findings show that nicotine worsens SARS-CoV-2 pulmonary infection and have implication for public health policies.
Search related documents:
Co phrase search for related documents- absence presence and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- absence presence and longitudinal observational study: 1, 2
- absence presence and low airway: 1
- absence presence and low extent: 1
- absence presence and low prevalence: 1, 2, 3, 4
- absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
- acid extraction and acute infection: 1, 2, 3, 4, 5, 6, 7
- acid extraction and low prevalence: 1, 2, 3, 4, 5, 6
- acid extraction and lung tissue: 1, 2
- acute infection and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute infection and longitudinal observational study: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute infection and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- acute infection and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- liver disease and longitudinal observational study: 1
- liver disease and low prevalence: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date